Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 301–400 of 964
Kettering, K., Weig, H., Reimold, M., Schwegler, A. C., Busch, M., Laszlo, R., Gawaz, M., & Schreieck, J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0182-2 · Cited by 18
“However, it should be mentioned that the effect of catheter ablation on the left ventricular function has been studied systematically in only rather small trials so far [7] and requires further investigation.”
BackgroundVentricular Tachycardia Ablation – The Right Approach for the Right Patient
Sadek, M. M., Schaller, R. D., Supple, G. E., Frankel, D. S., Riley, M. P., Hutchinson, M. D., Garcia, F. C., Lin, D., Dixit, S., Zado, E. S., et al. (2014) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2014.3.3.161 · Cited by 18
Kück, K. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.896571 · Cited by 22
Matching Ablation Endpoints to Long-Term Outcome
Radinovic, A., Peretto, G., Sgarito, G. A., Cauti, F. M., Castro, A., Narducci, M. L., Mantovan, R., Scaglione, M., Solimene, F., Scopinaro, A., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.10.038 · Cited by 17
Echivard, M., Sellal, J., Ziliox, C., Marijon, É., Bordachar, P., Ploux, S., Bénali, K., Marquié, C., Docq, C., Klug, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae575 · Cited by 19
Penela, D., Falasconi, G., Soto‐Iglesias, D., Fernández‐Armenta, J., Zucchelli, G., Bisbal, F., Záraket, F., Silva, E., Parollo, M., Latini, A. C., et al. (2025) · EP Europace · doi:10.1093/europace/euaf051 · Cited by 17
Enhancement of intracardiac navigation by new GPS-guided location system (MediGuide Technologies)
Gaspar, T., Kircher, S., Arya, A., Sommer, P., Rolf, S., Hindricks, G., & Piorkowski, C. (2012) · EP Europace · doi:10.1093/europace/eus215 · Cited by 17
Ventricular Tachycardia Ablation Clinical Trials
Liang, J. J., Muser, D., & Santangeli, P. (2016) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2016.10.012 · Cited by 17
Ventricular Tachycardia Ablation in the Elderly
Vakil, K. P., García, S., Tung, R. H., Vaseghi, M., Tedrow, U. B., Bella, P. E. D., Frankel, D. S., Vergara, P., Biase, L. D., Nagashima, K., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005332 · Cited by 17
Runge, M., Ibrahim, E.-S. H., Bogun, F. M., Attili, A. K., Mahani, M. G., Pang, Y., Horwood, L. E., Chenevert, T. L., & Stojanovska, J. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.21187 · Cited by 18
Substrate-based approaches in ventricular tachycardia ablation
Hawson, J. J., Al‐Kaisey, A., Anderson, R. D., Watts, T. W., Morton, J. B., Kumar, S., Kistler, P. M., Kalman, J. M., & Lee, G. (2022) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2022.08.002 · Cited by 17
Liang, J. J., Khurshid, S. S., Schaller, R. D., Santangeli, P., Marchlinski, F. E., & Frankel, D. S. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.03.005 · Cited by 17
“nuscript received January 5, 2015; revised manuscript received February and decrease heart failure hospitalizations compared with medical therapy alone (6,7).”
BackgroundRole of drugs and devices in patients at risk of sudden cardiac death
Boriani, G., Diemberger, I., Valzania, C., Biffi, M., Martignani, C., Raschi, E., Mantovani, V., Ziacchi, M., Bertini, M., Ponti, F. D., et al. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00853.x · Cited by 17
Lüsebrink, U., Duncker, D., Hess, M., Heinrichs, I., Gardiwal, A., Oswald, H., König, T., & Klein, G. G. (2013) · EP Europace · doi:10.1093/europace/eus430 · Cited by 17
“Slow VTs might be important regarding appropriate device selection (single- or dual-chamber devices),(6,7) programming of enhanced tachycardia detection algorithms,(8) or lower tachycardia detection zones and indication for catheter ablation.(9) However, the incidence and clinical significance of slow VTs beyond 187 b.”
BackgroundDagres, N., Cantu, F., Geelen, P., Lewalter, T., Proclemer, A., & Blomström‐Lundqvist, C. (2011) · EP Europace · doi:10.1093/europace/eur411 · Cited by 17
Gatzoulis, K. A., Archontakis, S., Dilaveris, P., Tsiachris, D., Αρσένος, Π., Sideris, S. K., & Stefanadis, C. (2011) · PubMed · Cited by 17
Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease
Virk, S. A., & Kumar, S. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.09.002 · Cited by 16
Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease
Garcia, J., Arya, A., Dinov, B., Bollmann, A., ter Bekke, R. M. A., Vernooy, K., Dagres, N., Hindricks, G., & Darma, A. (2023) · EP Europace · doi:10.1093/europace/euad367 · Cited by 16
Scarà, A., Palamà, Z., Robles, A. G., Dei, L., Borrelli, A., Zanin, F., Pignalosa, L., Romano, S., & Sciarra, L. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11040122 · Cited by 18
“For patients with ischemic cardiomyopathy and an ICD, both catheter ablation and antiarrhythmic drugs have been shown to decrease the occurrence of ICD shocks in randomized trials [45–47].”
BackgroundRadiofrequency Catheter Ablation for Ventricular Tachycardia
Haqqani, H. M., & Roberts‐Thomson, K. C. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2011.10.015 · Cited by 16
HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011
Link, M. S., Exner, D. V., Anderson, M. E., Ackerman, M., Al‐Ahmad, A., Knight, B. P., Markowitz, S. M., Kaufman, E. S., Haines, D. E., Asirvatham, S. J., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.008 · Cited by 16
da Silva, G. L., Nunes-Ferreira, A., Cortez‐Dias, N., de Sousa, J., Pinto, F. J., & Caldeira, D. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00870-3 · Cited by 18
Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention
Feng, Y., & Feng, X. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203087 · Cited by 18
“…Tachycardia Ablation in Coronary Heart Disease (VTACH) and the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachy-cardia (SMASH-VT) trials, the time and frequency of recurrent VT/VF were significantly longer and decreased in patients who received ablation treatment [69, 70].”
BackgroundRoujol, S., Basha, T., Tan, A. Y., Khanna, V., Chan, R. H. M., Moghari, M. H., Rayatzadeh, H., Shaw, J. L., Josephson, M. E., & Nezafat, R. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2233738 · Cited by 16
Self-citationNuclear Imaging Guidance for Ablation of Ventricular Arrhythmias
Duell, J., Dilsizian, V., Smith, M. F., Chen, W., & Dickfeld, T. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-015-0697-2 · Cited by 16
Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease
Betensky, B. P., & Marchlinski, F. E. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0742-9 · Cited by 16
“those with an ICD who did not have the procedure [12]. They found a significant reduction in appropriate ICD therapies in patients randomized to the catheter ablation arm (33 vs. 12 %, p=0.007) over an average of 22.5±5.5 mos follow-up. While there were no significant mortality differences, there was a trend toward im…”
ResultInfluentialAntiarrhythmic Drugs and Strategies
Opie, L. H., Dimarco, J., & Gersh, B. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-6158-8.50013-7 · Cited by 17
Role of Ablation Therapy in Ventricular Arrhythmias
Das, M. K., Dandamudi, G., & Steiner, H. A. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.03.010 · Cited by 16
Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator
Looi, K., Tang, A., & Agarwal, S. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133550 · Cited by 17
Clemens, M., Peichl, P., Wichterle, D., Pavlů, L., Cihak, R. J., Aldhoon, B., & Kautzner, J. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12751 · Cited by 15
Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge
Proietti, R., Joza, J. E., & Essebag, V. (2015) · The Journal of Physiology · doi:10.1113/jp270534 · Cited by 16
“Two randomized trials, SMASH-VT (Reddy et al. 2007) and VTach (Kuck et al. 2010), demonstrated that VT ablation reduces the burden of appropriate ICD therapy.”
MethodKonstantino, Y., Shafat, T., Novack, V., Novack, L., & Amit, G. (2015) · PubMed · Cited by 15
Elsokkari, I., Sapp, J. L., Doucette, S. P., Parkash, R., Gray, C. J., Gardner, M. J., Macintyre, C. J., & AbdelWahab, A. M. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0396-1 · Cited by 15
Smoczyńska, A., Beekman, J. D. M., & Vos, M. A. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.16.2 · Cited by 15
“Additional treatment, such as antiarrhythmic drugs or radio frequency ablation, are often used as adjunctive therapy to reduce the number of ICD-shocks, but both therapeutic modalities expose the patient to potentially adverse effects.(11,12) This underscores the importance of finding alternative therapies that interv…”
BackgroundSex differences in ventricular arrhythmia: epidemiology, pathophysiology and catheter ablation
Krisai, P., Cheniti, G., Takagi, T., Kamakura, T., Surget, E., André, C., Duchâteau, J., Pambrun, T., Derval, N., Sacher, F., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2301014 · Cited by 17
Sex and racial disparities in catheter ablation
Vandenberk, B., Chew, D. S., Parkash, R., & Gillis, A. M. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.08.002 · Cited by 15
Hayase, J. H., Tung, R. H., Narayan, S. M., & Krummen, D. E. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.049 · Cited by 15
Nair, M., Yaduvanshi, A., Kataria, V., & Kumar, M. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9556-2 · Cited by 15
“Substrate base ablation using 3D electroanatomical mapping has been used with good success rates in ablation of VT in complex substrates such as post-infarction [24] and cardiomyopathies; however, in the study by Dalal et al.”
MethodVentricular Tachycardia Ablation
Mittnacht, A. J. C., Dukkipati, S. R., & Mahajan, A. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000556 · Cited by 15
Deneke, T., Borggrefe, M., Hindricks, G., Kirchhof, P. F., Kück, K., Stellbrink, C., & Eckardt, L. (2017) · Der Kardiologe · doi:10.1007/s12181-016-0115-z · Cited by 15
Treatment of persistent ventricular tachycardia: Drugs or ablation?
Macintyre, C. J., & Sapp, J. L. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.05.004 · Cited by 15
Use of Bipolar Radiofrequency Catheter Ablation in the Treatment of Cardiac Arrhythmias
Souček, F., & Stárek, Z. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180524100608 · Cited by 15
“The ventricular wall thickness and related inability to achieve transmural lesion using standard UPA is one of the factors which may contribute to high reported rates of VT recurrence after RFA reaching 12-47% [4, 5].”
BackgroundBreitenstein, A., Sawhney, V., Providencia, R. A., Honarbakhsh, S., Ullah, W., Dhinoja, M., SCHILLING, R. J., Babu, G. G., CHOW, A. W. C., Lambiase, P. D., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.099 · Cited by 15
“Several studies have utilized a substrate-based VT ablation technique targeting channels within scar in sinus rhythm, often with good effect and with very low complication rates (11, 14, 19, 20, 30-33).”
BackgroundInfluentialAntiarrhythmic drugs and strategies
Nattel, S., Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00017-x · Cited by 17
2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death
Mikhailov, E. N., Gizatulina, T. P., Lebedev, D. S., Golukhova, E. Z., Kharlap, M. S., Лебедева, В. К., Bagnenko, S. F., Artyukhina, Е. А., Babokin, V. E., Batalov, R. E., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6670 · Cited by 17
Ujeyl, A., Inada, K., Hillmann, K., Wohlmuth, P., Kato, M., Tedrow, U. B., Stevenson, L. W., & Stevenson, W. G. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.05.003 · Cited by 14
Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia
Rottner, L., Metzner, A., Hochadel, M., Senges, J., Willems, S., İnce, H., Eckardt, L., Deneke, T., Lugenbiel, P., Brachmann, J., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034814 · Cited by 14
Cardiac MRI for Patients With Cardiac Implantable Electronic Devices
Stojanovska, J., Runge, M., Mahani, M. G., Cronin, P., Sayyouh, M., Bogun, F. M., & Ibrahim, E.-S. H. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.21883 · Cited by 14
Daidoji, H., Arimoto, T., Nitobe, J., Tamura, H., Kutsuzawa, D., Ishigaki, D., Ishino, M., Takahashi, H., Shishido, T., Miyashita, T., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.04.006 · Cited by 15
Sudden death: managing the patient who survives
Pachón, M., & Almendral, J. M. (2011) · Heart · doi:10.1136/hrt.2009.188375 · Cited by 14
“The role of catheter ablation as a primary prevention therapy of malignant ventricular arrhythmias at the time of ICD implantation in patients with a chronic myocardial infarction is still a controversial issue because, despite the proven reduction in arrhythmic episodes and ICD shocks, a reduction in mortality or imp…”
BackgroundSustained ventricular tachycardia in structural heart disease
Hadid, C. (2015) · Cardiology Journal · doi:10.5603/cj.a2014.0069 · Cited by 15
Ablation of ischemic ventricular tachycardia
Baldinger, S. H., Stevenson, W. G., & John, R. M. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000237 · Cited by 14
“Two randomized trials [ventricular tachycardia ablation in coronary heart disease (VTACH) and Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT)] explored the use of catheter ablation in ICD recipients with prior myocardial infarction, ventricular tachycardia, and impaired left v…”
MethodResultThree-Dimensional Mapping of Cardiac Arrhythmias
Tsuchiya, T. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1523 · Cited by 14
Elektrischer Sturm: Definition, Häufigkeit, Ursachen und prognostische Implikationen
Israel, C. W., & Manegold, J. C. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0321-y · Cited by 16
Sivagangabalan, G., Pouliopoulos, J., Huang, K., Barry, M. A., Lu, J., Thomas, S. P., Ross, D. L., Thiagalingam, A., & Kovoor, P. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.842872 · Cited by 14
Misra, S. K., Zahid, S., Prakosa, A., Saju, N., Tandri, H. S., Berger, R. D., Marine, J. E., Calkins, H. G., Zipunnikov, V. M., Trayanova, N. A., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.05.031 · Cited by 14
A Clinical Review of Ventricular Arrhythmias in Patients with Congestive Heart Failure
Al-Hadithi, A., & Boyle, N. (2019) · EMJ Cardiology · doi:10.33590/emjcardiol/18-00058r1 · Cited by 15
Schaeffer, B. N., Tanigawa, S., Nakamura, T., Muthalaly, R. G., Sapp, J. L., John, R. M., Ghidoli, D., Pellegrini, C. P., Tedrow, U. B., & Stevenson, W. G. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.10.007 · Cited by 14
König, S., Ueberham, L., Mueller-Roething, R., Wiedemann, M., Ulbrich, M., Sause, A., Tebbenjohanns, J., Schade, A., Shin, D., Staudt, A., et al. (2019) · EP Europace · doi:10.1093/europace/euz260 · Cited by 14
Waight, M. C., Prakosa, A., Li, A. C., Truong, A., Bunce, N., Marciniak, A., Trayanova, N. A., & SABA, M. M. (2025) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.013660 · Cited by 13
Sapp, J. L., TANG, A. S. L., Parkash, R., Stevenson, W. G., Healey, J. S., & Wells, G. A. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.04.009 · Cited by 14
Catheter Ablation for Ventricular Arrhythmias
Nof, E., Stevenson, W. G., & John, R. M. (2013) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2013.2.1.45 · Cited by 13
“The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) study included patients presenting for the first time with VF, haemodynamically unstable VT, or syncope with inducible VT during invasive electrophysiological testing.(9) Ablation to modify the arrhythmia substrate significan…”
BackgroundMethodGunda, S., Padala, S. K., Saini, A., Kang, L., Ellenbogen, K. A., & Koneru, J. N. (2018) · EP Europace · doi:10.1093/europace/euy213 · Cited by 13
Arrhythmia in Cardiomyopathy: Sex and Gender Differences
Kim, S. K., Bennett, R. G., Ingles, J., Kumar, S., & Zaman, S. J. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00531-0 · Cited by 13
“However, women were significantly under-represented, comprising only 7–16% of the overall enrolled population in these trials [42, 44, 45].”
BackgroundSantangeli, P., Alcalde, Ó., Zado, E. S., Callans, D. J., & Marchlinski, F. E. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12444 · Cited by 13
Sawhney, V., Breitenstein, A., Ullah, W., Finlay, M., Sporton, S. C., Earley, M. J., CHOW, A. W. C., Dhinoja, M., Lambiase, P. D., SCHILLING, R. J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.113 · Cited by 13
Patel, C., Yan, G., Kocovic, D. Z., & Kowey, P. R. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.893628 · Cited by 13
Shirai, Y., Liang, J. J., Hirao, K., Hyman, M. C., Kumareswaran, R., Arkles, J., Schaller, R. D., Supple, G. E., Frankel, D. S., Nazarian, S., et al. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.09.014 · Cited by 13
Chen, W., Qian, P. C., Boeck, M., Bredfeldt, J. S., Blankstein, R., Tedrow, U. B., Mak, R. H., & Zei, P. C. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15259 · Cited by 13
Preventing ventricular tachycardia with catheter ablation
Stevenson, W. G., & Tedrow, U. B. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61915-2 · Cited by 13
Economic analyses in cardiac electrophysiology: from clinical efficacy to cost utility
Frausing, M. H. J. P., Nielsen, J. C., Westergaard, C. L., Gerdes, C., Kjellberg, J., Boriani, G., & Kronborg, M. B. (2024) · EP Europace · doi:10.1093/europace/euae031 · Cited by 12
Santoro, F., Mugnai, G., Perrotta, L., Kovacs, B., Dinshaw, L., Castillo, A. M. D., Jungen, C., Kurath‐Koller, S., Stojković, S., Vandenberk, B., et al. (2025) · EP Europace · doi:10.1093/europace/euaf302 · Cited by 12
Dev, S., Peterson, P. N., Wang, Y., Curtis, J. P., Varosy, P. D., & Masoudi, F. A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.023 · Cited by 12
Management of Ventricular Tachycardia in Heart Failure
Baher, A. A., & Valderrábano, M. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-1-20 · Cited by 12
“10, 11 rFCa uses thermal energy to ablate the myocardium that serves as substrate for re-entrant vt circuits. recent advances in three-dimensional (3d) electroanatomical mapping systems enable reconstruction of vt circuit pathways during sinus rhythm, allowing rFCa in patients with unmappable vts.…”
Noten, A. M. E., Hendriks, A., Yap, S., Mol, D., Bhagwandien, R. E., Wijchers, S. A., Kardys, I., Khan, M., & Szili‐Törok, T. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.05.028 · Cited by 12
Al-Sheikhli, J., Patchett, I., Lim, V. G., Marshall, L., Foster, W., Kuehl, M. W., Yusuf, S., Panikker, S., Patel, K., Osman, F., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01158-4 · Cited by 12
Catheter ablation of ventricular tachycardia: strategies to improve outcomes
Subramanian, M., Atreya, A. R., Saggu, D. K., Yalagudri, S. D., & Narasimhan, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.966634 · Cited by 15
“Catheter ablation has an important role in the management of patients with ventricular tachycardia (VT) (1, 2).”
BackgroundCatheter ablation of ventricular tachycardia: Two decades of progress
Wilber, D. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.001 · Cited by 12
Short‐term outcomes associated with inpatient ventricular tachycardia catheter ablation
Sharma, P., Tripathi, B., Naraparaju, V., Patel, M. B., Bhagat, A. K., Yerasi, C., Kumar, V. M., Aujla, P. S., Singh, G., Lahewala, S., et al. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13905 · Cited by 12
The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia
Proietti, R., Licchelli, L., Lellouche, N., & Dhanjal, T. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12489 · Cited by 12
Electrical Substrate Ablation for Refractory Ventricular Fibrillation: Results of the AVATAR Study
Krummen, D. E., Ho, G., Hoffmayer, K. S., Schweis, F., Baykaner, T., Rogers, A. J., Han, F. T., Hsu, J. C., Viswanathan, M. N., Wang, P. J., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008868 · Cited by 14
Guckel, D., Niemann, S., Ditzhaus, M., Molatta, S., Bergau, L., Fink, T., Sciacca, V., Hamriti, M. E., Imnadze, G., Steinhauer, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204695 · Cited by 12
Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach
Sultan, A., Lüker, J., Hoffmann, B. A., Servatius, H., Aydın, A., Nührich, J. M., Akbulak, Ö., Schreiber, D., Schäffer, B., Rostock, T., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.003 · Cited by 12
“Despite the widespread use of ICD VT ablation in patients with SHD can abolish or diminish VT occurrence and therefore reduce ICD shocks, morbidity and potentially mortality [3,5,6,28].”
BackgroundVentricular tachycardia and ventricular fibrillation
Srivathsan, K. S., Ng, D. W., & Mookadam, F. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.69 · Cited by 13
Deneke, T., Lawo, T., Grewe, P., Calcum, B., Rausse, R., Bösche, L., Shin, D., Zarse, M., Horlitz, M., Mügge, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.038 · Cited by 12
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate
AbdelWahab, A. M., & Sapp, J. L. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0924-0 · Cited by 13
Localization of ventricular activation origin using patient‐specific geometry: Preliminary results
Zhou, S., Sapp, J. L., AbdelWahab, A. M., Šťovíček, P., & Horáček, B. M. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13622 · Cited by 12
“Two approaches to localization of activation origin were tested: (1) A statistical method, based onmultiple linear regression (MLR), which required only the conventional 12-lead ECG for a sufficient numberof pacing siteswith knownorigin togetherwithpatient-specific geometry of the endocardial/epicardial surfaceobtaine…”
MethodManagement of monomorphic ventricular tachycardia electrical storm in structural heart disease
AlKalbani, A., & Al‐Rawahi, N. (2019) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2019.05.001 · Cited by 12
“Also, prophylactic CA at the time of ICD implantation in patients with history of myocardial infarction, significantly decreased ICD therapies [53,54].”
BackgroundSandhu, U. G., Kovacs, A. H., & Nazer, B. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.09.011 · Cited by 13
Oates, C. P., Basyal, B., Whang, W., Reddy, V. Y., & Koruth, J. S. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.043 · Cited by 11
Self-citationKawada, S., Chakraborty, P., Downar, E., Sanchez, A.-P., Sathananthan, G., Bhaskaran, A. P., Kugamoorthy, P., Albertini, L., Oechslin, E. N., Silversides, C., et al. (2021) · CJC Open · doi:10.1016/j.cjco.2021.01.005 · Cited by 11
“Prophylactic substrate-based RFCA is safe and has also been shown to reduce the incidence of ICD therapy for the secondary prevention of SCD in patients with ischemic cardiomyopathy.(12) Twelve (25.”
BackgroundFalasconi, G., Penela, D., Soto‐Iglesias, D., Francia, P., Teres, C. C., Viveros, D., Bellido, A. F., Alderete, J. F., Meca-Santamaria, J., Franco-Ocaña, P., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01392-w · Cited by 11
Management of Ventricular Arrhythmias in Heart Failure
Vázquez‐Calvo, S., Roca‐Luque, I., & Althoff, T. F. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00608-y · Cited by 12
Endocardial ablation of postinfarction ventricular tachycardia with nonendocardial exit sites
Sinno, M., Yokokawa, M., Good, E. D., Oral, H., Pelosi, F., Chugh, A., Jongnarangsin, K., Ghanbari, H., Latchamsetty, R., Morady, F., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.02.009 · Cited by 11
Self-citationRecommendations for the Programming of Implantable Cardioverter-Defibrillators in New Zealand
Webber, M. R., & Stiles, M. K. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.07.017 · Cited by 12
Acosta, J., Cabanelas, N., Penela, D., Fernández‐Armenta, J., Andreu, D., Borràs, R., Коршунов, В. В., Cabrera, M., Vasanelli, F., Arbelo, E., et al. (2016) · EP Europace · doi:10.1093/europace/euw096 · Cited by 13
Tilz, R. R., Eitel, C., Lyan, E., Yalın, K., Liosis, S., Vogler, J., Brueggemann, B., Eitel, I., Heeger, C.-H. H., AlTurki, A., et al. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.31.3 · Cited by 11
Electrical Storm: Current Evidence, Clinical Implications, and Future Perspectives
Kontogiannis, C., Tampakis, K., Georgiopoulos, G. A., Bartoletti, S., Papageorgiou, C., Anninos, H., Kapelouzou, A., Spartalis, Μ., PARASKEVAIDIS, I. A., & Chatzidou, S. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1190-0 · Cited by 11
Secondary prevention of sudden cardiac death
Chatterjee, N. A., & Rea, T. D. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.08.002 · Cited by 11
Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia
Mircea, A. A., Rusu, M., Liehn, E. A., & Bucur, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012612 · Cited by 13
“Two studies showed that recurrency of VT in ischemic heart disease is successfully preventable with catheter ablation [34,35].”
Background
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.